マイクロニードルインフルエンザワクチンの世界市場レポート 2025年

マイクロニードルインフルエンザワクチン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.4％で24億8,000万米ドルに成長します。予測期間中に予想される成長の原動力は、パンデミック対策イニシアチブの拡大、針を使わないワクチン接種方法への嗜好の高まり、インフルエンザ以外の疾患へのマイクロニードルの幅広い応用、患者に優しいワクチン接種オプションへの需要の高まり、マイクロニードルパッチの製造拡大性の強化です。この期間の主要動向には、溶解可能なマイクロニードル技術へのシフト、自己投与ワクチンモデルへの注目の高まり、マイクロニードルとウェアラブル健康モニタリングシステムとの統合、マイクロニードルベースのインフルエンザワクチンの臨床検査の増加、小児と高齢者集団へのマイクロニードルプラットフォームの採用などがあります。

針恐怖症の有病率の増加は、マイクロニードルインフルエンザワクチン市場の成長を促進すると予想されます。針恐怖症は、トリパノフォビアとしても知られ、針を使った処置の光景、感覚、予期によって引き起こされる強い恐怖や不安であり、多くの場合、必要な医療介入を避けるように個人を導きます。この症状は、主に心理的過敏と過去の否定的な経験によって引き起こされ、長期的な恐怖と回避行動を引き起こします。マイクロニードルインフルエンザワクチンは、低侵襲でほとんど痛みのない代替手段を提供し、ワクチン接種に対する心理的障壁を軽減し、患者のコンプライアンスを向上させています。例えば、2025年2月、米国臨床病理学会（ASCP）は、小児の約50％から60％が注射針恐怖症を経験し、その恐怖は4歳から6歳の間に最も蔓延していると報告しました。その結果、針恐怖症の有病率の増加がマイクロニードルインフルエンザワクチン市場の拡大に寄与しています。

マイクロニードルインフルエンザワクチン市場の主要企業は、パッチ型RNAワクチンの開発を加速させるための投資確保に注力しています。このような取り組みにより、早期段階の研究や共同研究が支援され、次世代ワクチンデリバリー技術が前進しています。例えば、2024年3月、米国の政府機関であるBiomedical Advanced Research and Development Authority（BARDA）は、インフルエンザやCOVID-19を標的としたマイクロニードルパッチベースのRNAワクチンの開発を迅速に進めるため、Patch Forward Prizeを通じて5,000万米ドルの投資を行うことを発表しました。このイニシアチブは、コンセプト開発に資金を提供し、組み合わせ製品の第I相臨床検査への移行を支援することで、技術革新を推進することを目的としています。このプログラムは、技術的・規制的課題を克服し、ワクチンへのアクセス性を向上させ、感染症に対する国家的な備えを強化することを目的として、ワクチン開発者とパッチ製造業者間の協力を促進するものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のマイクロニードルインフルエンザワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のマイクロニードルインフルエンザワクチン市場：成長率分析
• 世界のマイクロニードルインフルエンザワクチン市場の実績：規模と成長、2019～2024年
• 世界のマイクロニードルインフルエンザワクチン市場の予測：規模と成長、2024～2029年、2034年
• 世界のマイクロニードルインフルエンザワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマイクロニードルインフルエンザワクチン市場：製品タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 中空マイクロニードル
• 固体マイクロニードル
• コーティングマイクロニードル
• 溶解マイクロニードル
• 世界のマイクロニードルインフルエンザワクチン市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 非経口
• 鼻腔
• 世界のマイクロニードルインフルエンザワクチン市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のマイクロニードルインフルエンザワクチン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• インフルエンザ予防接種
• 季節性インフルエンザの予防
• 小児ワクチン
• 高齢者向けワクチン
• 世界のマイクロニードルインフルエンザワクチン市場、中空マイクロニードルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 使い捨て中空マイクロニードル
• 多用途中空マイクロニードル
• ポリマーベースの中空マイクロニードル
• シリコンベースの中空マイクロニードル
• 世界のマイクロニードルインフルエンザワクチン市場、固体マイクロニードルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 金属固体マイクロニードル
• シリコン固体マイクロニードル
• ポリマー固体マイクロニードル
• ガラス固体マイクロニードル
• 世界のマイクロニードルインフルエンザワクチン市場、コーティングマイクロニードルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤コーティングマイクロニードル
• ワクチンコーティングマイクロニードル
• 生分解性コーティングマイクロニードル
• ナノコーティングマイクロニードル
• 世界のマイクロニードルインフルエンザワクチン市場、溶解マイクロニードルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 速溶性マイクロニードル
• 徐放性マイクロニードル
• ハイドロゲルベースの溶解マイクロニードル
• 糖ベースの溶解マイクロニードル

第7章 地域別・国別分析

• 世界のマイクロニードルインフルエンザワクチン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のマイクロニードルインフルエンザワクチン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マイクロニードルインフルエンザワクチン市場：競合情勢
• マイクロニードルインフルエンザワクチン市場：企業プロファイル
  • Merck & Co. Inc.
  • Sanofi SA
  • AstraZeneca plc
  • Novartis AG
  • Becton Dickinson and Company（BD）

第31章 その他の大手企業と革新的企業

• AptarGroup
• Corium International
• CosMED Pharmaceutical Co. Ltd.
• Vaxxas
• PharmaJet
• Inovio Pharmaceuticals
• Vaxess Technologies
• FluGen Inc.
• DebIoTech S.A.
• Micron Biomedical Inc.
• NanoPass Technologies Limited
• Micropoint Technologies Pte Ltd.
• TSRL Inc.
• Verndari Inc.
• Microdermics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• マイクロニードルインフルエンザワクチン市場、2029年：新たな機会を提供する国
• マイクロニードルインフルエンザワクチン市場、2029年：新たな機会を提供するセグメント
• マイクロニードルインフルエンザワクチン市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

The microneedle flu vaccine is an innovative vaccination method that uses a small, patch-like array of microscopic needles to painlessly deliver the influenza vaccine into the skin. This approach offers a minimally invasive, efficient, and user-friendly alternative to traditional intramuscular injections. It is designed to enhance vaccine accessibility, increase patient compliance, facilitate self-administration, and improve immunization coverage, especially in large-scale public health initiatives.

The main product types of microneedle flu vaccines include hollow microneedles, solid microneedles, coated microneedles, and dissolving microneedles. A hollow microneedle is a micro-scale needle with a central lumen, allowing for the direct injection of liquid formulations into the skin. These vaccines can be administered through various routes, such as oral, parenteral, and nasal, and are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Applications for these vaccines include flu vaccination, seasonal flu prevention, pediatric vaccines, and vaccines for the elderly.

The microneedle flu vaccine market research report is one of a series of new reports from The Business Research Company that provides microneedle flu vaccine market statistics, including microneedle flu vaccine industry global market size, regional shares, competitors with a microneedle flu vaccine market share, detailed microneedle flu vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle flu vaccine industry. This microneedle flu vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The microneedle flu vaccine market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the increasing global burden of seasonal influenza, rising awareness about the benefits of vaccination, government efforts to improve immunization coverage, a growing preference for minimally invasive drug delivery methods, and the early clinical success of microneedle vaccines in animal models.

The microneedle flu vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period is driven by the expansion of pandemic preparedness initiatives, increasing preference for needle-free vaccination methods, broader application of microneedles for diseases beyond influenza, rising demand for patient-friendly vaccination options, and enhanced manufacturing scalability of microneedle patches. Key trends during this period include a shift toward dissolvable microneedle technologies, a growing focus on self-administered vaccine models, integration of microneedles with wearable health monitoring systems, a rise in clinical trials for microneedle-based influenza vaccines, and the adoption of microneedle platforms for pediatric and elderly populations.

The increasing prevalence of needle phobia is expected to drive the growth of the microneedle flu vaccine market. Needle phobia, also known as trypanophobia, is an intense fear or anxiety triggered by the sight, sensation, or anticipation of needle-based procedures, often leading individuals to avoid necessary medical interventions. This condition is primarily fueled by psychological sensitivity and negative past experiences, creating long-term fear and avoidance behavior. Microneedle flu vaccines provide a minimally invasive and nearly painless alternative, which reduces psychological barriers to vaccination and encourages better patient compliance. For example, in February 2025, the American Society for Clinical Pathology (ASCP) reported that approximately 50% to 60% of children experience needle phobia, with the fear being most prevalent between the ages of 4 and 6. As a result, the growing prevalence of needle phobia is contributing to the expansion of the microneedle flu vaccine market.

Leading companies in the microneedle flu vaccine market are focusing on securing investments to accelerate the development of patch-based RNA vaccines. These efforts support early-stage research and collaboration, advancing next-generation vaccine delivery technologies. For example, in March 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based government agency, announced a $50 million investment through the Patch Forward Prize to fast-track the development of microneedle patch-based RNA vaccines targeting influenza and COVID-19. This initiative aims to drive innovation by funding concept development and supporting the progression of combination products into Phase I clinical trials. The program fosters collaboration between vaccine developers and patch manufacturers, with the goal of overcoming technical and regulatory challenges, improving vaccine accessibility, and bolstering national preparedness for infectious diseases.

In January 2024, Gylden Pharma Limited (formerly Emergex Vaccines Holding Limited), a UK-based clinical-stage biotechnology company, partnered with DEKA Research & Development Corp. to enhance patient-friendly drug delivery through advanced microneedle-based intradermal administration technologies. The collaboration seeks to evaluate the compatibility and effectiveness of combining Emergex's immunotherapeutic candidates with DEKA's microneedle applicator for potential clinical use. DEKA Research & Development Corp., a U.S.-based company specializing in microneedle solutions, will play a pivotal role in advancing this technology.

Major players in the microneedle flu vaccine market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Novartis AG, Becton Dickinson and Company (BD), AptarGroup, Corium International, CosMED Pharmaceutical Co. Ltd., Vaxxas, PharmaJet, Inovio Pharmaceuticals, Vaxess Technologies, FluGen Inc., Debiotech S.A., Micron Biomedical Inc., NanoPass Technologies Limited, Micropoint Technologies Pte Ltd., TSRL Inc., Verndari Inc., and Microdermics Inc.

North America was the largest region in the microneedle flu vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microneedle flu vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the microneedle flu vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The microneedle flu vaccine market consists of sales of polymer-based microneedle patches, hydrogel-forming microneedles, silicon microneedle arrays, biodegradable microneedle systems, metallic microneedles, and lipid-based microneedle formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microneedle Flu Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microneedle flu vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for microneedle flu vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle flu vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Hollow Microneedle; Solid Microneedle; Coated Microneedle; Dissolving Microneedle
• 2) By Route Of Administration: Oral; Parenteral; Nasal
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By Application: Flu Vaccination; Seasonal Flu Prevention; Pediatric Vaccines; Elderly Vaccines
• Subsegments:
• 1) By Hollow Microneedle: Single-Use Hollow Microneedles; Multiple-Use Hollow Microneedles; Polymer-Based Hollow Microneedles; Silicon-Based Hollow Microneedles
• 2) By Solid Microneedle: Metal Solid Microneedles; Silicon Solid Microneedles; Polymer Solid Microneedles; Glass Solid Microneedles
• 3) By Coated Microneedle: Drug-Coated Microneedles; Vaccine-Coated Microneedles; Biodegradable Coated Microneedles; Nano-Coated Microneedles
• 4) By Dissolving Microneedle: Fast-Dissolving Microneedles; Slow-Release Microneedles; Hydrogel-Based Dissolving Microneedles; Sugar-Based Dissolving Microneedles
• Companies Mentioned: Merck & Co. Inc.; Sanofi SA; AstraZeneca plc; Novartis AG; Becton Dickinson and Company (BD)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Microneedle Flu Vaccine Market Characteristics

3. Microneedle Flu Vaccine Market Trends And Strategies

4. Microneedle Flu Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microneedle Flu Vaccine Growth Analysis And Strategic Analysis Framework

• 5.1. Global Microneedle Flu Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Microneedle Flu Vaccine Market Growth Rate Analysis
• 5.4. Global Microneedle Flu Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Microneedle Flu Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Microneedle Flu Vaccine Total Addressable Market (TAM)

6. Microneedle Flu Vaccine Market Segmentation

• 6.1. Global Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hollow Microneedle
• Solid Microneedle
• Coated Microneedle
• Dissolving Microneedle
• 6.2. Global Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Nasal
• 6.3. Global Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Microneedle Flu Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flu Vaccination
• Seasonal Flu Prevention
• Pediatric Vaccines
• Elderly Vaccines
• 6.5. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Hollow Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Hollow Microneedles
• Multiple-Use Hollow Microneedles
• Polymer-Based Hollow Microneedles
• Silicon-Based Hollow Microneedles
• 6.6. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Solid Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metal Solid Microneedles
• Silicon Solid Microneedles
• Polymer Solid Microneedles
• Glass Solid Microneedles
• 6.7. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Coated Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug-Coated Microneedles
• Vaccine-Coated Microneedles
• Biodegradable Coated Microneedles
• Nano-Coated Microneedles
• 6.8. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Dissolving Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fast-Dissolving Microneedles
• Slow-Release Microneedles
• Hydrogel-Based Dissolving Microneedles
• Sugar-Based Dissolving Microneedles

7. Microneedle Flu Vaccine Market Regional And Country Analysis

• 7.1. Global Microneedle Flu Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Microneedle Flu Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Microneedle Flu Vaccine Market

• 8.1. Asia-Pacific Microneedle Flu Vaccine Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Microneedle Flu Vaccine Market

• 9.1. China Microneedle Flu Vaccine Market Overview
• 9.2. China Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Microneedle Flu Vaccine Market

• 10.1. India Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Microneedle Flu Vaccine Market

• 11.1. Japan Microneedle Flu Vaccine Market Overview
• 11.2. Japan Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Microneedle Flu Vaccine Market

• 12.1. Australia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Microneedle Flu Vaccine Market

• 13.1. Indonesia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Microneedle Flu Vaccine Market

• 14.1. South Korea Microneedle Flu Vaccine Market Overview
• 14.2. South Korea Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Microneedle Flu Vaccine Market

• 15.1. Western Europe Microneedle Flu Vaccine Market Overview
• 15.2. Western Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Microneedle Flu Vaccine Market

• 16.1. UK Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Microneedle Flu Vaccine Market

• 17.1. Germany Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Microneedle Flu Vaccine Market

• 18.1. France Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Microneedle Flu Vaccine Market

• 19.1. Italy Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Microneedle Flu Vaccine Market

• 20.1. Spain Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Microneedle Flu Vaccine Market

• 21.1. Eastern Europe Microneedle Flu Vaccine Market Overview
• 21.2. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Microneedle Flu Vaccine Market

• 22.1. Russia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Microneedle Flu Vaccine Market

• 23.1. North America Microneedle Flu Vaccine Market Overview
• 23.2. North America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Microneedle Flu Vaccine Market

• 24.1. USA Microneedle Flu Vaccine Market Overview
• 24.2. USA Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Microneedle Flu Vaccine Market

• 25.1. Canada Microneedle Flu Vaccine Market Overview
• 25.2. Canada Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Microneedle Flu Vaccine Market

• 26.1. South America Microneedle Flu Vaccine Market Overview
• 26.2. South America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Microneedle Flu Vaccine Market

• 27.1. Brazil Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Microneedle Flu Vaccine Market

• 28.1. Middle East Microneedle Flu Vaccine Market Overview
• 28.2. Middle East Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Microneedle Flu Vaccine Market

• 29.1. Africa Microneedle Flu Vaccine Market Overview
• 29.2. Africa Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Microneedle Flu Vaccine Market Competitive Landscape And Company Profiles

• 30.1. Microneedle Flu Vaccine Market Competitive Landscape
• 30.2. Microneedle Flu Vaccine Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis

31. Microneedle Flu Vaccine Market Other Major And Innovative Companies

• 31.1. AptarGroup
• 31.2. Corium International
• 31.3. CosMED Pharmaceutical Co. Ltd.
• 31.4. Vaxxas
• 31.5. PharmaJet
• 31.6. Inovio Pharmaceuticals
• 31.7. Vaxess Technologies
• 31.8. FluGen Inc.
• 31.9. Debiotech S.A.
• 31.10. Micron Biomedical Inc.
• 31.11. NanoPass Technologies Limited
• 31.12. Micropoint Technologies Pte Ltd.
• 31.13. TSRL Inc.
• 31.14. Verndari Inc.
• 31.15. Microdermics Inc.

32. Global Microneedle Flu Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microneedle Flu Vaccine Market

34. Recent Developments In The Microneedle Flu Vaccine Market

35. Microneedle Flu Vaccine Market High Potential Countries, Segments and Strategies

• 35.1 Microneedle Flu Vaccine Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Microneedle Flu Vaccine Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Microneedle Flu Vaccine Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer